Claims for Patent: 8,765,189

Summary for Patent: 8,765,189

Title:	Organophosphorous and multivalent metal compound compositions and methods
Abstract:	Compositions and methods of their use to adhere a variety of materials together are disclosed herein. The compositions include at least multivalent metal compound, an effective amount of a compound that is structurally similar to phosphoserine, and can be mixed with an aqueous solution. The compositions provide adhesive and cohesive strength in both wet and dry environments which exhibit bond strength upon curing with the possible usage as bone cement for bone filler applications.
Inventor(s):	Garigapati; Venkat R. (Southborough, MA), TenHuisen; Kevor S. (Boulder, CO)
Assignee:	Howmedica Osteonic Corp. (Mahwah, NJ)
Application Number:	13/469,806
Patent Claims:	1. An adhesive composition comprising: a multivalent metal compound; and a compound of the formula: ##STR00033## wherein R is one of Groups I, II, III, IV, V, VI, or VII: ##STR00034## wherein X is selected from the group consisting of Groups Ia, Ib, Ic, Id, and Ie: ##STR00035## where n is an integer from 0 to 6, and R.sub.1 is a carboxylic acid group, a sodium carboxylic acid salt or Group If: ##STR00036## where R.sub.2 is selected from the group consisting of Groups IIa, IIb, IIc, IId, IIe, and IIf, a pyridoxyl group, a nicotinic acid group, a salicylic acid group, and a tyrosine group; ##STR00037## where n is an integer from 1 to 11; ##STR00038## wherein X.sub.1 is a linking group selected from the group consisting of C1 to C12 aliphatic diols, aromatic diols, Group IIIa, sugar, monosaccharides, and disaccharides; ##STR00039## wherein m and n are each integers from 1 to 2 and y is a number from 1 to 100; ##STR00040## wherein the compound comprises a phosphoserine oligomer or a phosphoserine capped polymer of Group IV having from 2 to 10 repeating groups, and wherein X.sub.2 is selected from one or more amino acids of Groups IVa, IVb, or IVc, polyesters selected from homopolymers and copolymers of caprolactone, lactide, glycolide, hydroxybutyrate, ethylene glycol linked phosphoserine, and mixtures thereof; ##STR00041## wherein n is a number from 1 to 50, wherein the polylactic glycolic acid (PLGA) of Group IVb has a ratio of lactic acid to glycolic acid being from about 0:100 to about 100:0, more preferably from about 30:70 to about 50:50, and the PLGA may be linear, hyperbranched, or star shaped; ##STR00042## wherein the compound exists in one of the L, D, and racemic forms; ##STR00043## wherein the compound exists in one of the L, D, and racemic forms; ##STR00044## wherein R.sub.3 is H or --P(O)(OH).sub.2, and wherein the compound exists in one of the L, D, and racemic forms; wherein the compound is present in an amount from about 10% to about 90% by weight based on the combined weight of the multivalent metal compound and the compound; and an aqueous medium in an amount of up to about 35% by weight based on the combined weight of the multivalent metal compound, the compound, and the aqueous medium. 2. The composition of claim 1 wherein the multivalent metal compound is selected from the cation group consisting of calcium, magnesium, barium, strontium, iron, zinc, titanium, zirconium, and mixtures thereof. 3. The composition of claim 2 wherein the multivalent metal compound is selected from the group consisting of tetracalcium phosphate, tricalcium phosphate, tristrontium phosphate, and tetrastrontium phosphate. 4. The composition of claim 1 wherein the multivalent metal compound is selected from the anion group consisting of phosphates, oxides, carbonates, bicarbonates, sulfates, hydroxides, chlorides, acetates, fatty acid salts, acetylacetones, nitrates, and mixtures thereof. 5. The composition of claim 1 wherein the multivalent metal compound is crystalline, amorphous, or mixtures thereof. 6. The composition of claim 1 wherein the compound is present in an amount from about 15% to about 50% by weight based on the combined weight of the multivalent metal compound and the compound. 7. The composition of claim 1 wherein the aqueous medium is present in an amount from about 14% to about 19% by weight of the total composition. 8. The composition of claim 1 wherein the compound is selected from the group consisting of tyrosine phosphate, threonine phosphate, 3,4-dihydroxyphenylalanine (DOPA) monophosphate, DOPA diphosphate, and mixtures thereof. 9. The composition of claim 1 wherein the compound is phosphoserine, tyrosine phosphate, theronine phosphate, DOPA monophosphate, and DOPA diphosphate. 10. The composition of claim 1 wherein the multivalent metal compound has a mean particle size of less than 1000 microns. 11. The composition of claim 1 wherein the aqueous medium is water. 12. The composition of claim 1 wherein the aqueous medium is a blood based product. 13. The composition of claim 1 that further includes an additive. 14. The composition of claim 13 wherein the additive is selected from the group consisting of alpha tri-calcium phosphate, beta tri-calcium phosphate, calcium sulfate, calcium silicate, calcium carbonate, sodium bicarbonate, sodium chloride, potassium chloride, glycerol phosphate disodium, amino acids, polyols, trehalose, lactose, sucrose, silk, keratin, autologous bone powder or chips, demineralized bone powder, demineralized bone chips, collagen, biodegradable polymers, bone morphogenetic protein 7, stem cells, parathyroid hormone, bisphosphonates, and mixtures thereof. 15. The composition of claim 13 wherein the additive is a reaction rate modifier. 16. The composition of claim 13 wherein the additive is a pore former. 17. The composition of claim 13 wherein the additive enhances resorption. 18. The composition of claim 13 wherein the additive is a strength modifier. 19. The composition of claim 13 wherein the additive promotes bone healing. 20. The composition of claim 13 wherein the additive is a contrast agent. 21. The composition of claim 1 wherein the composition has a tacky state for up to about 12 minutes after mixing with the aqueous medium. 22. The composition of claim 21 wherein the composition during the tacky state has a separation strength in the range of about 10 kPa to about 250 kPa after mixing with the aqueous medium. 23. The composition of claim 1 wherein the composition has a putty state for up to about 15 minutes after mixing with the aqueous medium. 24. The composition of claim 1 wherein the composition has a working time for up to about 26 minutes after mixing with the aqueous medium. 25. The composition of claim 1 wherein the composition has an adhesive strength upon curing of greater than 250 kPa. 26. The composition of claim 25 wherein the adhesive strength is for bone to a non-bone material. 27. The composition of claim 25 wherein the adhesive strength is for bone to bone. 28. The composition of claim 25 wherein the adhesive strength is for non-bone material to non-bone material. 29. The composition of claim 1 wherein the composition is resorbable by the body. 30. The composition of claim 1 wherein the compound is present in an amount from about 20% to about 40% by weight based on the combined weight of the multivalent metal compound and the compound. 31. The composition of claim 1 wherein the composition has a tacky state for up to about 4 minutes after mixing with the aqueous medium. 32. The composition of claim 1 wherein the composition has a tacky state for up to about 2 minutes after mixing with the aqueous medium. 33. The composition of claim 21 wherein the composition during the tacky state has a separation strength in the range of about 50 kPa to about 150 kPa after mixing with the aqueous medium. 34. The composition of claim 1 wherein the composition has a putty state for up to about 8 minutes after mixing with the aqueous medium. 35. The composition of claim 1 wherein the composition has a putty state for up to about 5 minutes after mixing with the aqueous medium. 36. The composition of claim 1 wherein the composition has a working time for up to about 12 minutes after mixing with the aqueous medium. 37. The composition of claim 1 wherein the composition has a working time for up to about 7 minutes after mixing with the aqueous medium.

Details for Patent 8,765,189

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015		2039-03-29